Improving cancer control policies in Nigeria
Policy implementation for cancer control in Nigeria
['FUNDING_OTHER'] · WASHINGTON UNIVERSITY · NIH-11093714
This study is all about finding better ways to help decision-makers in Nigeria use scientific research to improve cancer prevention, especially for cancers that can be prevented by vaccines, like cervical and liver cancer, by understanding how they make choices and sharing useful information with them.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | WASHINGTON UNIVERSITY (nih funded) |
| Locations | 1 site (SAINT LOUIS, UNITED STATES) |
| Trial ID | NIH-11093714 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the use of scientific evidence in policy decisions related to cancer control in Nigeria. It aims to understand how policymakers make decisions and to develop effective strategies for disseminating research findings that can influence these decisions. By conducting interviews and mapping exercises, the study will identify the characteristics and preferences of policy actors involved in cancer control. The ultimate goal is to create tailored communication strategies that promote the use of evidence for preventing vaccine-preventable cancers like cervical and liver cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals in Nigeria who are at risk for vaccine-preventable cancers, particularly cervical and liver cancer.
Not a fit: Patients outside of Nigeria or those not at risk for vaccine-preventable cancers may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer control policies in Nigeria, ultimately reducing the incidence of vaccine-preventable cancers.
How similar studies have performed: While there is limited research on this specific approach in Africa, similar studies in other regions have shown success in improving policy decisions through evidence dissemination.
Where this research is happening
SAINT LOUIS, UNITED STATES
- WASHINGTON UNIVERSITY — SAINT LOUIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: IWELUNMOR, JULIET — WASHINGTON UNIVERSITY
- Study coordinator: IWELUNMOR, JULIET
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Control, Cancer Control Research, Cancer Control Science, Cancers, Cervical Cancer